✦ LIBER ✦

Efficacy and safety of canagliflozin compared with placebo and sitagliptin in patients with type 2 diabetes on background metformin monotherapy: a randomised trial

✍ Scribed by Lavalle-González, F. J.; Januszewicz, A.; Davidson, J.; Tong, C.; Qiu, R.; Canovatchel, W.; Meininger, G.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of monotherapy of si

✍ P. Aschner; H. L. Katzeff; H. Guo; S. Sunga; D. Williams-Herman; K. D. Kaufman; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 628 KB

Efficacy and safety of canagliflozin ove

✍ Forst, T.; Guthrie, R.; Goldenberg, R.; Yee, J.; Vijapurkar, U.; Meininger, G.; 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 622 KB

Efficacy and safety of sitagliptin monot

✍ Kenji Nonaka; Taro Kakikawa; Asako Sato; Kotoba Okuyama; Go Fujimoto; Naoki Kato 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 405 KB

Efficacy and safety of sitagliptin monot

✍ Y. Iwamoto; N. Tajima; T. Kadowaki; K. Nonaka; T. Taniguchi; M. Nishii; J. C. Ar 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 642 KB

Efficacy and safety of saxagliptin in co

✍ André J. Scheen; Guillaume Charpentier; Carl Johan Östgren; Åsa Hellqvist; Ingri 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 237 KB

Efficacy and Safety of Canagliflozin, a

✍ Leiter, Lawrence A.; Cefalu, William T.; Niskanen, Leo; Xie, John; Millington, D 📂 Article 📅 2012 🏛 Canadian Diabetes Association 🌐 English ⚖ 62 KB